Latest Gene therapy Stories
Program leverages experience with lead Phase 3 program in inherited retinal dystrophies (IRDs) and expands relationship with the Center for Retinal and Ocular Therapy at the University of Pennsylvania
VANCOUVER, Jan. 20, 2015 /PRNewswire/ - RepliCel Life Sciences Inc.
SAN DIEGO, Jan. 15, 2015 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced the election of the following three new directors: Mr.
ROTTERDAM, the Netherlands, January 14, 2015 /PRNewswire/ -- Treeway B.V., founded by entrepreneurs Bernard Muller and Robbert Jan Stuit, both diagnosed with ALS, have
PARIS, January 7, 2015 /PRNewswire/ -- This public - private project with an overall budget of EUR 47 million aims to restore vision to legally blind patients with
-- CHOP Gene Therapy Expert Fine-Tunes Protein Signals, Improves Motor Function and Reduces Brain Shrinkage in a Neurological Disorder -- PHILADELPHIA, Jan.
Using modified human stem cells, a team of UC Davis scientists has developed an improved gene therapy strategy that in animal models shows promise as a functional cure for the human immunodeficiency
In a new “proof of concept” experiment, scientists have managed to edit the genome of sperm-producing adult stem cells, creating a break in the DNA strands of a mutant gene in mouse cells then repairing it by replacing flawed segments with corrected ones.
Former head of rare diseases at Genzyme brings a 20-year track record of delivering successful, innovative products to patients throughout the world PHILADELPHIA, Dec.
More Images (1 images) »